Dendreon Corp fka DNDNQ

[ocyanblue]

<This would be done in case the alpha allocated for the interim look is in the 0.01-0.015 range, but 9902B's interim p value comes back between 0.015 and 0.05. The FDA would have to bend its Pazdurian standards somewhat to grant approval in this example>

Agree. I said earlier on iVillage that this might be a good reason for DNDN to tread lightly around the FDA despite recent events. ENCY did not manage their relationship with the FDA well.

http://www1.investorvillage.com/smbd.asp?mb=971&mn=137616&pt=msg&mid=2421916